Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

Allergy·2023

The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.

Andrology·2019

L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.

Cell death and differentiation·2014

Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.

Reumatismo·2012

The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice.

British journal of pharmacology·2010

Emerging Role of AI in Single-Cell Sequencing Toward Biomarker Discovery, Therapeutic Target Identification and Precision Medicine in Lung Cancer.

Critical reviews in oncology/hematology·2026

Prognostic value of circulating tumor DNA in esophageal and gastric cancer by treatment stage: a systematic review and meta-analysis.

Critical reviews in oncology/hematology·2026

Cardiovascular Toxicities Associated With Immune Checkpoint Inhibitors: Clinical Phenotypes, Mechanisms, Diagnosis, and Management-A Narrative Review.

Critical reviews in oncology/hematology·2026

Survival by Design: Cell Fate Dynamics in Classical Hodgkin Lymphoma.

Critical reviews in oncology/hematology·2026

When is 4 Gy enough? Defining dose sufficiency and durable control in indolent B-cell lymphoma.

Critical reviews in oncology/hematology·2026

Rewiring the Tumor-Immune Ecosystem: Extracellular Vesicles in the Next Era of Cancer Immunotherapy.

Critical reviews in oncology/hematology·2026

Brief Report: Combination Capmatinib and Trametinib in Metastatic MET-Driven NSCLC.

JTO clinical and research reports·2026

Correction: GOLPH3 inhibits glioma cell apoptosis through the JNK signaling pathway.

Frontiers in genetics·2026

Application of Dual-Targeting Carbon Dot Nanozymes in Improving Hypoxia and Enhancing Small Interfering RNA-Mediated Gene Silencing for Hepatocellular Carcinoma.

Biomaterials research·2026

First demonstration of benzosultam CRBN ligand-mediated PROTACs for BTK and BRD4 degradation.

RSC medicinal chemistry·2026

Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation.

Materials today. Bio·2026

Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers.

Frontiers in immunology·2026

Related Experiment Videos

Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy

Related Concept Videos

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.

L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.

Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.

The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice.

Emerging Role of AI in Single-Cell Sequencing Toward Biomarker Discovery, Therapeutic Target Identification and Precision Medicine in Lung Cancer.

Prognostic value of circulating tumor DNA in esophageal and gastric cancer by treatment stage: a systematic review and meta-analysis.

Cardiovascular Toxicities Associated With Immune Checkpoint Inhibitors: Clinical Phenotypes, Mechanisms, Diagnosis, and Management-A Narrative Review.

Survival by Design: Cell Fate Dynamics in Classical Hodgkin Lymphoma.

When is 4 Gy enough? Defining dose sufficiency and durable control in indolent B-cell lymphoma.

Rewiring the Tumor-Immune Ecosystem: Extracellular Vesicles in the Next Era of Cancer Immunotherapy.

Brief Report: Combination Capmatinib and Trametinib in Metastatic MET-Driven NSCLC.

Correction: GOLPH3 inhibits glioma cell apoptosis through the JNK signaling pathway.

Application of Dual-Targeting Carbon Dot Nanozymes in Improving Hypoxia and Enhancing Small Interfering RNA-Mediated Gene Silencing for Hepatocellular Carcinoma.

First demonstration of benzosultam CRBN ligand-mediated PROTACs for BTK and BRD4 degradation.

Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation.

Why only 3 months? Immunological constraints on CAR-T therapy in gastrointestinal cancers.

Related Experiment Videos

Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy

Related Concept Videos

Related Articles